The mid-term efficacy of intra-articular hyaluronic acid injections on joint structure: a nested case control study

REFERENCES

• Sharma L, Kapoor D. Epidemiology of osteoarthritis. In: Mo-skowitz RW, Altman RD, Hochberg MC, Buckwalter JA, Gold-berg VM, editors. Osteoarthritis: diagnosis and medical/surgical management. 4th ed. Philadelphia: Lippincott Williams & Wil-kins; 2007. p. 3–26.
   Google Scholar
• Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PW, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84:351–8.
   PubMed Web of Science ®Google Scholar
• Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthr Rheum. 1998;41:1343–55.
   PubMed Web of Science ®Google Scholar
• Iwata H. Pharmacologic and clinical aspects of intraarticular injec-tion of hyaluronate. Clin Orthop Relat Res. 1993;289:285–91.
   PubMed Web of Science ®Google Scholar
• Caborn D, Rush J, Lanzer W, Parenti D, Murray C. A random-ized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol. 2004;31: 333–43.
   Google Scholar
• Jones AC, Pattrick M, Doherty S, Doherty M. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hex-acetonide in inflammatory knee osteoarthritis. Osteoarthr Cartil. 1995;3:269–73.
   PubMed Web of Science ®Google Scholar
• Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheu-matol. 1998;25:2203–12.
   Google Scholar
• Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthr Cartil. 1993;1:97–103.
   PubMedGoogle Scholar
• Petrella RJ, Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol. 2006;33:951–6.
   PubMed Web of Science ®Google Scholar
• Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): clinical results. Osteoarthr Cartil. 2002;10:506–17.
   PubMed Web of Science ®Google Scholar
• Tamir E, Robinson D, Koren R, Agar G, Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol. 2001;19:265–70.
   Google Scholar
• Waddell DD, Bricker DC. Clinical experience with the effec-tiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg. 2006;19:19–27.
   PubMedGoogle Scholar
• Forster MC, Straw R. A prospective randomised trial comparing intra-articular Hyalgan injection and arthroscopic washout for knee osteoarthritis. Knee. 2003;10:291–3.
   PubMed Web of Science ®Google Scholar
• Raman R, Dutta A, Day N, Sharma HK, Shaw CJ, Johnson GV. Efficacy of Hylan G.-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee-a prospective randomized clinical trial. Knee. 2008;15:318–24.
   Google Scholar
• Waddell DD. Viscosupplementation with hyaluronans for osteo-arthritis of the knee: clinical efficacy and economic implications. Drugs Aging. 2007;24:629–42.
   PubMed Web of Science ®Google Scholar
• Bellamy N, Campbell J, Robinson V, Gee T, Boume R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;19:CD005321.
   Google Scholar
• Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil. 2010;18:476–99.
   PubMed Web of Science ®Google Scholar
• Brandt KD, Smith GN, Simon LS. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis. What is the evi-dence? Arthr Rheum. 2000;43:1192–203.
   Google Scholar
• Listrat V, Ayral X, Patamello F, Bonvarlet JP, Simonnet J, Amor B, et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthr Cartil. 1997;5:153–60.
   PubMed Web of Science ®Google Scholar
• Jubb RW, Piva S, Beinat L, Dacre J, Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500–730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract. 2003;57: 467–74.
   Google Scholar
• Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502.
   PubMed Web of Science ®Google Scholar
• Altman RD, Hochberg M, Murphy WA Jr, Wolfe F, Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthr Cartil. 1995;3(Suppl A):3–70.
   Google Scholar
• Altman RD, Gold GE. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthr Cartil. 2007;15(Suppl A):A1–56.
   Google Scholar
• Oka H, Muraki S, Akune T, Mabuchi A, Suzuki T, Yoshida H, et al. Fully automatic quantification of knee osteoarthritis severity on plain radiographs. Osteoarthr Cartil. 2008;16:1300–6.
   PubMed Web of Science ®Google Scholar
• Muraki S, Oka H, Akune T, Mabuchi A, En-yo Y, Yoshida M, et al. Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study. Osteoarthr Cartil. 2009;17: 1137–43.
   Google Scholar
• Yoshimura N, Muraki S, Oka H, Mabuch A, En-yo Y, Yoshida M, et al. Prevalence of knee osteoarthritis, lumbar spondylosis and osteoporosis in Japanese men and women: the Research on Osteoarthritis/Osteoporosis Against Disability (ROAD). J Bone Miner Metab. 2009;27:620–8.
   Google Scholar
• Muraki S, Oka H, Mabuchi A, Akune T, En-yo Y, Yoshida M, et al. Prevalence of radiographic lumbar spondylosis and its association with low back pain in the elderly of population-based cohorts: the ROAD study. Ann Rheum Dis. 2009;68:1401–6.
   Google Scholar
• Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Cohort profile: Research on Osteoarthritis/Osteoporosis Against Disability study. Int J Epidemiol. 2010;39:988–95.
   PubMed Web of Science ®Google Scholar
• Cabom D, Rush J, Lanzer W, Parenti D, Murray C. A random-ized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol. 2004;31: 333–43.
   Google Scholar
• Linaker CH, Walker-Bone K, Palmer K, Cooper C. Frequency and impact of regional musculoskeletal disorders. Baillieres Clin Rheumatol. 1999;13:197–215.
   PubMed Web of Science ®Google Scholar
• Summers MN, Haley WE, Reveille JD, Alarcon GS. Radio-graphic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. Arthr Rheum. 1988;31:204–9.
   PubMed Web of Science ®Google Scholar
• Cicuttini FM, Baker J, Hart DJ, Spector TD. Association of pain with radiological changes in different compartments and views of the knee joint. Osteoarthr Cartil. 1996;4:143–7.
   PubMed Web of Science ®Google Scholar
• Wluka AE, Wolfe R, Stuckey S, Cicuttini FM. How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis? Ann Rheum Dis. 2004;63:264–8.
   Google Scholar
• Day R, Brooks P, Conaghan PG, Petersen M. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol. 2004;31:775–82.
   PubMed Web of Science ®Google Scholar
• Shimazu A, Jikko A, Iwamoto M, Koike T, Yan W, Okada Y, et al. Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthr Rheum. 1993;36:247–53.
   PubMedGoogle Scholar
• Gotoh S, Onaya J, Abe M, Miyazaki K, Hamai A, Hone K, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis. 1993;52:817–22.
   PubMed Web of Science ®Google Scholar
• Asari A, Miyauchi S, Matsuzaka S, Ito T, Kominami E, Uchiy-ama Y. Molecular weight-dependent effects of hyaluronate on the arthritic synovium. Arch Histol Cytol. 1998;61:125–35.
   PubMedGoogle Scholar
• Altman RD. Non-avian-derived hyaluronan for the treatment of osteoarthritis of the knee. Expert Rev Clin Immunol. 2010;6: 21–7.
   PubMed Web of Science ®Google Scholar